TNF and acute myeloid leukemia: Similarly, diosmin in acute myeloid leukemia treatment caused a decrease in tumor cell growth through caspase‐8 activation and increased TNF‐α expression (Roma et al., 2018) and also downregulated the active proteins in the G0–G1 cell cycle phase, like Cdk2, Cdk4, and cyclin D1.